BioSpace News Archive

Israel’s Accelerated Evolution Biotechnologies Claims a Cure for Cancer

Accelerated Evolution Biotechnologies(AEBi)’s claims to have found a cure for cancer are, appropriately, being met with global skepticism. Learn more about it here.

January 30, 2019
·
3 min read
·
Mark Terry
Career Advice

4 Reasons Why You Didn’t Get the Job

When you are constantly hearing, “Thank you for your time, but we went with another candidate,” or you’re regularly submitting applications online, but not ever getting a response back, it can be frustrating.

January 30, 2019
·
3 min read
·
Porschia Parker
Drug Development

A Long Line of Alzheimer’s Failures: Roche Drops Two Drug Trials

Roche announced that it was discontinuing two of its Alzheimer’s Phase III trials, CREAD I and 2, after a pre-planned interim analysis.

January 30, 2019
·
3 min read
·
Mark Terry
Business

As Novartis Eyes Growth in 2019, the Company Will Likely Cut Some Prices

Novartis Chief Executive Officer Vas Narasimhan said 2018 was a year of reimagining for Switzerland-based Novartis. It was a year when the company focused its capital and resourced on developing breakthrough medicines.

January 30, 2019
·
3 min read
·
Alex Keown
Genetown

Is Biogen’s Aducanumab for Alzheimer’s the Holy Grail or Cold Fusion?

Whenever a drug fails an Alzheimer’s clinical trial, analysts, investors and industry watchers immediately turn to look at Biogen. Will the company’s aducanumab be the one? Will it be the drug that will actually break the string of more than 150 drug failures?

January 30, 2019
·
3 min read
·
Mark Terry
Drug Development

Eyenovia Announces Positive Results in the MicroStat MIST-1 Phase III Registration Study for Mydriasis

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced positive results from the MicroStat Phase 3 MIST-1 study.

January 30, 2019
·
8 min read
Deals

Changes to the Nomination Committee for Immunicum AB (publ)

Immunicum AB announced the composition of the Nomination Committee on 19 October 2018.

January 30, 2019
·
1 min read
Medtronic Announces Positive Results from the Largest ENB Study to Aid in Lung Cancer Diagnosis, Staging, and Treatment Preparation in a Single Minimally Invasive Procedure

Company Is Committed to Leading Evidence Generation Across the Lung Cancer Care Continuum

January 30, 2019
·
5 min read
Business

ASLAN, Aduro Initiate Corporate Restructuring That Includes Significant Layoffs

Singapore-based ASLAN slashed 30 percent of its staff following a recent mid-stage failure, and California-based Aduro has cut 37 percent of employees.

January 30, 2019
·
3 min read
·
Alex Keown
Policy

Lap Dances From an Insys Sales Executive Were Part of Insys’ Practices to Boost Sales of Subsys, Trial Shows

As the trial against John Kapoor and other former executives at Insys Therapeutics continues, more sordid details of an aggressive campaign to boost sales of the company’s fentanyl-based sublingual spray for cancer pain are being brought to light.

January 30, 2019
·
2 min read
·
Alex Keown